Literature DB >> 9266999

Human cytomegalovirus infection results in altered Cdk2 subcellular localization.

W A Bresnahan1, E A Thompson, T Albrecht.   

Abstract

Human cytomegalovirus (HCMV) stimulates numerous cellular pathways upon infection. One of these pathways involves activation of cyclin E/Cdk2. Recent reports have demonstrated that Cdk2 is retained in the cytoplasm of cells arrested in GO by serum deprivation, sequestered from its regulatory subunit cyclin E which is located within the nucleus. Cdk2 rapidly enters the nucleus and becomes active upon stimulation of these cells with serum growth factors. The ability of HCMV to activate cyclin E/Cdk2 in both serum-arrested cells and contact-inhibited cells suggests that HCMV infection may also result in the translocation of Cdk2 into the nucleus. In this report, we demonstrate that Cdk2 is sequestered in the cytoplasm of cells arrested in GO by contact inhibition, as well as those arrested by serum deprivation. HCMV infection results in translocation of Cdk2 from the cytoplasm into the nucleus within 24 h of infection, both in serum-arrested and contact-inhibited cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9266999     DOI: 10.1099/0022-1317-78-8-1993

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  19 in total

Review 1.  Strategies in subversion: de-regulation of the mammalian cell cycle by viral gene products.

Authors:  C Swanton; N Jones
Journal:  Int J Exp Pathol       Date:  2001-02       Impact factor: 1.925

2.  Cell cycle dysregulation by human cytomegalovirus: influence of the cell cycle phase at the time of infection and effects on cyclin transcription.

Authors:  B S Salvant; E A Fortunato; D H Spector
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

Review 3.  Human cytomegalovirus and human herpesvirus 6 genes that transform and transactivate.

Authors:  J Doniger; S Muralidhar; L J Rosenthal
Journal:  Clin Microbiol Rev       Date:  1999-07       Impact factor: 26.132

4.  Human cytomegalovirus up-regulates the phosphatidylinositol 3-kinase (PI3-K) pathway: inhibition of PI3-K activity inhibits viral replication and virus-induced signaling.

Authors:  R A Johnson; X Wang; X L Ma; S M Huong; E S Huang
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

5.  Murine cytomegalovirus stimulates cellular thymidylate synthase gene expression in quiescent cells and requires the enzyme for replication.

Authors:  G Gribaudo; L Riera; D Lembo; M De Andrea; M Gariglio; T L Rudge; L F Johnson; S Landolfo
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

6.  Inhibition of cyclin-dependent kinase 1 by purines and pyrrolo[2,3-d]pyrimidines does not correlate with antiviral activity.

Authors:  David L Evers; Julie M Breitenbach; Katherine Z Borysko; Leroy B Townsend; John C Drach
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

7.  Cell cycle-independent expression of immediate-early gene 3 results in G1 and G2 arrest in murine cytomegalovirus-infected cells.

Authors:  Lüder Wiebusch; Anke Neuwirth; Linus Grabenhenrich; Sebastian Voigt; Christian Hagemeier
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

8.  Origin licensing and p53 status regulate Cdk2 activity during G(1).

Authors:  Kathleen R Nevis; Marila Cordeiro-Stone; Jeanette Gowen Cook
Journal:  Cell Cycle       Date:  2009-06-21       Impact factor: 4.534

9.  Cyclin-dependent kinase activity is required at early times for accurate processing and accumulation of the human cytomegalovirus UL122-123 and UL37 immediate-early transcripts and at later times for virus production.

Authors:  Veronica Sanchez; Anita K McElroy; Judy Yen; Sama Tamrakar; Charles L Clark; Rachel A Schwartz; Deborah H Spector
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

10.  Pharmacological cyclin-dependent kinase inhibitors inhibit replication of wild-type and drug-resistant strains of herpes simplex virus and human immunodeficiency virus type 1 by targeting cellular, not viral, proteins.

Authors:  Luis M Schang; Andrew Bantly; Marie Knockaert; Farida Shaheen; Laurent Meijer; Michael H Malim; Nathanael S Gray; Priscilla A Schaffer
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.